Compare Cytokinetics Inc (CYTK) vs NetApp Inc. (NTAP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cytokinetics Inc vs NetApp Inc. — how do they compare? Cytokinetics Inc trades at $77.39 (market cap $10.63B), while NetApp Inc. trades at $199.79 (market cap $38.95B). The key difference: NetApp Inc. is far larger — about 3.7× Cytokinetics Inc's market cap, and NetApp Inc. pays a 1.05% dividend while Cytokinetics Inc pays none. Which is the better fit depends on your goals.
| CYTK | NTAP | |
|---|---|---|
Market Cap | $10.63B | $38.95B |
Sector | Technology | Technology |
52-Week High | $87.26 | $198.72 |
52-Week Low | $34.31 | $94.11 |
Enterprise Value | $10.74B | $38.10B |
Dividend Yield | — | 1.05% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →About NetApp Inc.
NetApp is a leading provider of enterprise data management and storage solutions. The company's three operating business units are products, software maintenance, and hardware maintenance. NetApp transitioned from a data center storage firm to a company with software data management solutions for multicloud environments. The California-headquartered company sells globally and has approximately 10,000 employees.
Read more on NTAP →
